Clinical study on the status of transient thyrotoxicosis after surgery for secondary hyperparathyroidism patients with end-stage renal disease and normal thyroid function

Abstract Objective Secondary hyperparathyroidism (SHPT) is a common complication of end-stage renal disease (ESRD), and part of SHPT patients need receive parathyroidectomy (PTX). However, as an important postoperative complication of SHPT, thyrotoxicosis has received little attention. Therefore, in...

Full description

Bibliographic Details
Main Authors: Bao-shan Zou, Jia-shuo Liu, Hong Li, Zhou Xu, Hao Li, Hong-yuan Li, Kai-nan Wu, Ling-quan Kong
Format: Article
Language:English
Published: BMC 2020-03-01
Series:European Journal of Medical Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40001-020-00405-6
id doaj-a286b16fd84949dcad550076d42a101e
record_format Article
spelling doaj-a286b16fd84949dcad550076d42a101e2020-11-25T02:15:36ZengBMCEuropean Journal of Medical Research2047-783X2020-03-012511510.1186/s40001-020-00405-6Clinical study on the status of transient thyrotoxicosis after surgery for secondary hyperparathyroidism patients with end-stage renal disease and normal thyroid functionBao-shan Zou0Jia-shuo Liu1Hong Li2Zhou Xu3Hao Li4Hong-yuan Li5Kai-nan Wu6Ling-quan Kong7Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical UniversityDepartment of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical UniversityDepartment of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical UniversityDepartment of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical UniversityDepartment of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical UniversityDepartment of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical UniversityDepartment of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical UniversityDepartment of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical UniversityAbstract Objective Secondary hyperparathyroidism (SHPT) is a common complication of end-stage renal disease (ESRD), and part of SHPT patients need receive parathyroidectomy (PTX). However, as an important postoperative complication of SHPT, thyrotoxicosis has received little attention. Therefore, in this article, we aimed to study the status of transient thyrotoxicosis after PTX for SHPT patients with ESRD and normal thyroid function. Methods A total of 24 SHPT patients with preoperative normal thyroid function, normal thyroglobulin (Tg) and normal thyroid antibodies receiving PTX were enrolled from the Department of Endocrine and Breast Surgery, the First Affiliated Hospital of Chongqing Medical University, from January 2017 to January 2019. Tg, high sensitivity thyrotropin stimulating hormone (sTSH), triiodothyronine (T3), free triiodothyronine (fT3), thyroxine (T4) and free thyroxine (fT4) were evaluated the day before PTX and on day 1, 3 and 5 after PTX. Besides, all enrolled patients were evaluated whether there are symptoms associated with thyrotoxicosis. Results Among the 24 SHPT patients, 1 case (4.2%), 8 cases (33.3%) and 13 cases (54.2%) had suffered thyrotoxicosis at the first, third and fifth day after surgery, respectively. Serum FT4 level increased significantly from pre-operation (0.68 ± 0.15 ng/dl, normal range 0.59–1.25 ng/dl) to the third day after operation (1.91 ± 0.97 ng/dl, p<0.001) and then gradually decline. The frequencies of serum sTSH lower than the normal level gradually increased from the first day (8.3%) to fifth day (66.7%) after surgery. Conclusion Transient thyrotoxicosis is a common postoperative complication of parathyroidectomy for SHPT patients with ESRD and normal thyroid function, and it is necessary for clinicians to evaluate the perioperative thyroid function to make early diagnosis and appropriate prevention and treatment of thyrotoxicosis.http://link.springer.com/article/10.1186/s40001-020-00405-6Chronic kidney diseaseEnd-stage renal diseaseSecondary hyperparathyroidismThyrotoxicosisParathyroidectomy
collection DOAJ
language English
format Article
sources DOAJ
author Bao-shan Zou
Jia-shuo Liu
Hong Li
Zhou Xu
Hao Li
Hong-yuan Li
Kai-nan Wu
Ling-quan Kong
spellingShingle Bao-shan Zou
Jia-shuo Liu
Hong Li
Zhou Xu
Hao Li
Hong-yuan Li
Kai-nan Wu
Ling-quan Kong
Clinical study on the status of transient thyrotoxicosis after surgery for secondary hyperparathyroidism patients with end-stage renal disease and normal thyroid function
European Journal of Medical Research
Chronic kidney disease
End-stage renal disease
Secondary hyperparathyroidism
Thyrotoxicosis
Parathyroidectomy
author_facet Bao-shan Zou
Jia-shuo Liu
Hong Li
Zhou Xu
Hao Li
Hong-yuan Li
Kai-nan Wu
Ling-quan Kong
author_sort Bao-shan Zou
title Clinical study on the status of transient thyrotoxicosis after surgery for secondary hyperparathyroidism patients with end-stage renal disease and normal thyroid function
title_short Clinical study on the status of transient thyrotoxicosis after surgery for secondary hyperparathyroidism patients with end-stage renal disease and normal thyroid function
title_full Clinical study on the status of transient thyrotoxicosis after surgery for secondary hyperparathyroidism patients with end-stage renal disease and normal thyroid function
title_fullStr Clinical study on the status of transient thyrotoxicosis after surgery for secondary hyperparathyroidism patients with end-stage renal disease and normal thyroid function
title_full_unstemmed Clinical study on the status of transient thyrotoxicosis after surgery for secondary hyperparathyroidism patients with end-stage renal disease and normal thyroid function
title_sort clinical study on the status of transient thyrotoxicosis after surgery for secondary hyperparathyroidism patients with end-stage renal disease and normal thyroid function
publisher BMC
series European Journal of Medical Research
issn 2047-783X
publishDate 2020-03-01
description Abstract Objective Secondary hyperparathyroidism (SHPT) is a common complication of end-stage renal disease (ESRD), and part of SHPT patients need receive parathyroidectomy (PTX). However, as an important postoperative complication of SHPT, thyrotoxicosis has received little attention. Therefore, in this article, we aimed to study the status of transient thyrotoxicosis after PTX for SHPT patients with ESRD and normal thyroid function. Methods A total of 24 SHPT patients with preoperative normal thyroid function, normal thyroglobulin (Tg) and normal thyroid antibodies receiving PTX were enrolled from the Department of Endocrine and Breast Surgery, the First Affiliated Hospital of Chongqing Medical University, from January 2017 to January 2019. Tg, high sensitivity thyrotropin stimulating hormone (sTSH), triiodothyronine (T3), free triiodothyronine (fT3), thyroxine (T4) and free thyroxine (fT4) were evaluated the day before PTX and on day 1, 3 and 5 after PTX. Besides, all enrolled patients were evaluated whether there are symptoms associated with thyrotoxicosis. Results Among the 24 SHPT patients, 1 case (4.2%), 8 cases (33.3%) and 13 cases (54.2%) had suffered thyrotoxicosis at the first, third and fifth day after surgery, respectively. Serum FT4 level increased significantly from pre-operation (0.68 ± 0.15 ng/dl, normal range 0.59–1.25 ng/dl) to the third day after operation (1.91 ± 0.97 ng/dl, p<0.001) and then gradually decline. The frequencies of serum sTSH lower than the normal level gradually increased from the first day (8.3%) to fifth day (66.7%) after surgery. Conclusion Transient thyrotoxicosis is a common postoperative complication of parathyroidectomy for SHPT patients with ESRD and normal thyroid function, and it is necessary for clinicians to evaluate the perioperative thyroid function to make early diagnosis and appropriate prevention and treatment of thyrotoxicosis.
topic Chronic kidney disease
End-stage renal disease
Secondary hyperparathyroidism
Thyrotoxicosis
Parathyroidectomy
url http://link.springer.com/article/10.1186/s40001-020-00405-6
work_keys_str_mv AT baoshanzou clinicalstudyonthestatusoftransientthyrotoxicosisaftersurgeryforsecondaryhyperparathyroidismpatientswithendstagerenaldiseaseandnormalthyroidfunction
AT jiashuoliu clinicalstudyonthestatusoftransientthyrotoxicosisaftersurgeryforsecondaryhyperparathyroidismpatientswithendstagerenaldiseaseandnormalthyroidfunction
AT hongli clinicalstudyonthestatusoftransientthyrotoxicosisaftersurgeryforsecondaryhyperparathyroidismpatientswithendstagerenaldiseaseandnormalthyroidfunction
AT zhouxu clinicalstudyonthestatusoftransientthyrotoxicosisaftersurgeryforsecondaryhyperparathyroidismpatientswithendstagerenaldiseaseandnormalthyroidfunction
AT haoli clinicalstudyonthestatusoftransientthyrotoxicosisaftersurgeryforsecondaryhyperparathyroidismpatientswithendstagerenaldiseaseandnormalthyroidfunction
AT hongyuanli clinicalstudyonthestatusoftransientthyrotoxicosisaftersurgeryforsecondaryhyperparathyroidismpatientswithendstagerenaldiseaseandnormalthyroidfunction
AT kainanwu clinicalstudyonthestatusoftransientthyrotoxicosisaftersurgeryforsecondaryhyperparathyroidismpatientswithendstagerenaldiseaseandnormalthyroidfunction
AT lingquankong clinicalstudyonthestatusoftransientthyrotoxicosisaftersurgeryforsecondaryhyperparathyroidismpatientswithendstagerenaldiseaseandnormalthyroidfunction
_version_ 1724895134633426944